IMO now is the time for the company to really get the PR wheels turning.We need this at least $2+ to get fair value in any kind of corporate activity.The recent rises have been extremely helpful for us but we need to see more.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%